Treatment and outcomes of pulmonary mucosa‐associated lymphoid tissue lymphoma: A multicenter analysis of 186 patients

Kazutaka Suzuki; Kana Miyazaki; Naoko Asano; Hiroyuki Takahashi; Yusuke Koba; Nobuhiro Hiramoto; Ilseung Choi; Hiroshi Arima; Toshiki Uchida; Nobuhiko Nakamura; Hiro Tatetsu; Hideki Uryu; Shunsuke Ito; Takeharu Kato; Hirokazu Sasaki; Tohru Murayama; Junji Hiraga; Naoki Takahashi; Tetsu Kobayashi; Motoshi Takao; Isao Tawara; Motoko Yamaguchi

doi:10.1002/cncr.70390

Key Points

This analysis aims to evaluate the treatment outcomes and survival rates of patients with pulmonary mucosa-associated lymphoid tissue lymphoma.
Multicenter analysis of 186 patients diagnosed with pulmonary MALT lymphoma.
Evaluation of overall survival and progression-free survival rates based on treatment modalities and disease stage.
Comparison of outcomes across different treatment approaches, including watchful waiting.
Overall survival (OS) rates were favorable across all first-line treatment modalities.
Progression-free survival (PFS) was notably short in stage IIE and IV groups, indicating a need for new therapies.
Findings suggest that patients in advanced stages could benefit from therapeutic advancements.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

This multicenter analysis shows favorable outcomes in pulmonary MALT lymphoma patients, suggesting future therapeutic development for certain stages.

Abstract

The OS of patients with MALT lymphoma with pulmonary involvement was favorable regardless of first-line treatment modality, including watchful waiting. The short PFS in the stage IIE and IV groups indicates that these groups are candidates for therapeutic development.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Suzuki et al. (2026) studied this question.

synapsesocial.com/papers/69d9e55278050d08c1b75925 https://doi.org/10.1002/cncr.70390

View Full Paper

Ask AI

Bookmark

Share

Treatment and outcomes of pulmonary mucosa‐associated lymphoid tissue lymphoma: A multicenter analysis of 186 patients

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Treatment and outcomes of pulmonary mucosa‐associated lymphoid tissue lymphoma: A multicenter analysis of 186 patients

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading